Think twice before plugging in. From malware-laden USB drives to fire-hazard cables, we list 5 devices that should stay far ...

Increased esophageal hypervigilance and anxiety were associated with worse post-treatment symptoms and poor quality of life ...

Final results from first pancreatic cancer study in Montreal demonstrate 81% disease control rate, or 87% excluding the first ...

ISC has received regulatory clearance from Singapore's HSA for CystoSmart, its AI software for bladder tumour detection.

AI has ability to improve digestive, liver, and gall bladder health. But there is a need for superior evidence to ensure ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...

Medical announced the release of final results from its first-in-human pancreatic cancer study in Montreal, Canada exploring the ...

According to the Kentucky Blood Center, each pint donated saves three lives. The WYMT winter blood drive collected 30 units ...

GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...